Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)

Zhiwei Liu; Troy J. Kemp; Yu Tang Gao; Amanda Corbel; Emma E. McGee; Juan Carlos Roa; Bingsheng Wang; Juan Carlos Araya; Ming Chang Shen; Asif Rashid; Ann W. Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M. Pfeiffer; Ligia A. Pinto; Jill Koshiol

doi:10.1038/s41598-020-59761-2

Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)

Zhiwei Liu, Troy J. Kemp, Yu Tang Gao, Amanda Corbel, Emma E. McGee, Juan Carlos Roa, Bingsheng Wang, Juan Carlos Araya, Ming Chang Shen, Asif Rashid, Ann W. Hsing, Allan Hildesheim, Catterina Ferreccio, Ruth M. Pfeiffer, Ligia A. Pinto, Jill Koshiol

Pathology, Anatomical

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

This Article contains errors in the Results section. “The median stage-adjusted survival time was 7.9 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” should read: “The median stage-adjusted survival time was 7.1 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” In addition, this Article contains errors in Table 1, where the reported numbers of patients under the ‘Regular Aspirin use’ subheading are incorrect. The correct totals for ‘No’ are 32 (100.0) and 97 (96.0) under Early-stage and Late-Stage respectively, and for ‘Yes’ the correct totals are 0 (0.0) and 4(4.0) respectively.

Original language	English (US)
Article number	2680
Journal	Scientific reports
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41598-020-59761-2
State	Published - Dec 1 2020

ASJC Scopus subject areas

General

Access to Document

10.1038/s41598-020-59761-2

Cite this

Liu, Z., Kemp, T. J., Gao, Y. T., Corbel, A., McGee, E. E., Roa, J. C., Wang, B., Araya, J. C., Shen, M. C., Rashid, A., Hsing, A. W., Hildesheim, A., Ferreccio, C., Pfeiffer, R. M., Pinto, L. A., & Koshiol, J. (2020). Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8). Scientific reports, 10(1), Article 2680. https://doi.org/10.1038/s41598-020-59761-2

Liu, Z, Kemp, TJ, Gao, YT, Corbel, A, McGee, EE, Roa, JC, Wang, B, Araya, JC, Shen, MC, Rashid, A, Hsing, AW, Hildesheim, A, Ferreccio, C, Pfeiffer, RM, Pinto, LA & Koshiol, J 2020, 'Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)', Scientific reports, vol. 10, no. 1, 2680. https://doi.org/10.1038/s41598-020-59761-2

@article{3f54cafc78a2457e9fe693a2ff407337,

title = "Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)",

abstract = "This Article contains errors in the Results section. “The median stage-adjusted survival time was 7.9 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” should read: “The median stage-adjusted survival time was 7.1 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” In addition, this Article contains errors in Table 1, where the reported numbers of patients under the {\textquoteleft}Regular Aspirin use{\textquoteright} subheading are incorrect. The correct totals for {\textquoteleft}No{\textquoteright} are 32 (100.0) and 97 (96.0) under Early-stage and Late-Stage respectively, and for {\textquoteleft}Yes{\textquoteright} the correct totals are 0 (0.0) and 4(4.0) respectively.",

author = "Zhiwei Liu and Kemp, {Troy J.} and Gao, {Yu Tang} and Amanda Corbel and McGee, {Emma E.} and Roa, {Juan Carlos} and Bingsheng Wang and Araya, {Juan Carlos} and Shen, {Ming Chang} and Asif Rashid and Hsing, {Ann W.} and Allan Hildesheim and Catterina Ferreccio and Pfeiffer, {Ruth M.} and Pinto, {Ligia A.} and Jill Koshiol",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41598-020-59761-2",

language = "English (US)",

volume = "10",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)

AU - Liu, Zhiwei

AU - Kemp, Troy J.

AU - Gao, Yu Tang

AU - Corbel, Amanda

AU - McGee, Emma E.

AU - Roa, Juan Carlos

AU - Wang, Bingsheng

AU - Araya, Juan Carlos

AU - Shen, Ming Chang

AU - Rashid, Asif

AU - Hsing, Ann W.

AU - Hildesheim, Allan

AU - Ferreccio, Catterina

AU - Pfeiffer, Ruth M.

AU - Pinto, Ligia A.

AU - Koshiol, Jill

PY - 2020/12/1

Y1 - 2020/12/1

N2 - This Article contains errors in the Results section. “The median stage-adjusted survival time was 7.9 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” should read: “The median stage-adjusted survival time was 7.1 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” In addition, this Article contains errors in Table 1, where the reported numbers of patients under the ‘Regular Aspirin use’ subheading are incorrect. The correct totals for ‘No’ are 32 (100.0) and 97 (96.0) under Early-stage and Late-Stage respectively, and for ‘Yes’ the correct totals are 0 (0.0) and 4(4.0) respectively.

AB - This Article contains errors in the Results section. “The median stage-adjusted survival time was 7.9 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” should read: “The median stage-adjusted survival time was 7.1 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).” In addition, this Article contains errors in Table 1, where the reported numbers of patients under the ‘Regular Aspirin use’ subheading are incorrect. The correct totals for ‘No’ are 32 (100.0) and 97 (96.0) under Early-stage and Late-Stage respectively, and for ‘Yes’ the correct totals are 0 (0.0) and 4(4.0) respectively.

UR - http://www.scopus.com/inward/record.url?scp=85079235407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079235407&partnerID=8YFLogxK

U2 - 10.1038/s41598-020-59761-2

DO - 10.1038/s41598-020-59761-2

M3 - Comment/debate

C2 - 32042030

AN - SCOPUS:85079235407

SN - 2045-2322

VL - 10

JO - Scientific reports

JF - Scientific reports

IS - 1

M1 - 2680

ER -

Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this